BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 28296734)

  • 1. Genetic anticipation in a special form of hypertrophic cardiomyopathy with sudden cardiac death in a family with 74 members across 5 generations.
    Guo X; Fan C; Wang Y; Wang M; Cai C; Yang Y; Zhao S; Duan F; Li Y
    Medicine (Baltimore); 2017 Mar; 96(11):e6249. PubMed ID: 28296734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MYH7 Gene-Related Mutation p.V878L Identified in a Chinese Family with Hypertrophic Cardiomyopathy.
    Du Y; Wang Y; Han X; Feng Z; Ma A
    Int Heart J; 2019 Nov; 60(6):1415-1420. PubMed ID: 31735781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical outcomes associated with sarcomere mutations in hypertrophic cardiomyopathy: a meta-analysis on 7675 individuals.
    Sedaghat-Hamedani F; Kayvanpour E; Tugrul OF; Lai A; Amr A; Haas J; Proctor T; Ehlermann P; Jensen K; Katus HA; Meder B
    Clin Res Cardiol; 2018 Jan; 107(1):30-41. PubMed ID: 28840316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual LQT1 and HCM phenotypes associated with tetrad heterozygous mutations in KCNQ1, MYH7, MYLK2, and TMEM70 genes in a three-generation Chinese family.
    Wang L; Zuo L; Hu J; Shao H; Lei C; Qi W; Liu Y; Miao Y; Ma X; Huang CL; Wang B; Zhou X; Zhang Y; Liu L
    Europace; 2016 Apr; 18(4):602-9. PubMed ID: 25825456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Analysis of MYH7, MYBPC3 and TNNT2 gene mutations in 10 Chinese pedigrees with familial hypertrophic cardiomyopathy and the correlation between genotype and phenotype].
    Liu WL; Xie WL; Hu DY; Zhu TG; Li YT; Sun YH; Li CL; Li L; Li TC; Bian H; Tong QG; Yang SN; Fan RY; Cui W
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Mar; 34(3):202-7. PubMed ID: 16630449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Family screening for hypertrophic cardiomyopathy: Is it time to change practice guidelines?
    Lafreniere-Roula M; Bolkier Y; Zahavich L; Mathew J; George K; Wilson J; Stephenson EA; Benson LN; Manlhiot C; Mital S
    Eur Heart J; 2019 Dec; 40(45):3672-3681. PubMed ID: 31170284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of variants in MYH7, MYBPC3 and TNNT2 with sudden cardiac death-related risk factors in Brazilian patients with hypertrophic cardiomyopathy.
    Mori AA; Castro LR; Bortolin RH; Bastos GM; Oliveira VF; Ferreira GM; Hirata TDC; Fajardo CM; Sampaio MF; Moreira DAR; Pachón-Mateos JC; Correia EB; Sousa AGMR; Brión M; Carracedo A; Hirata RDC; Hirata MH
    Forensic Sci Int Genet; 2021 May; 52():102478. PubMed ID: 33588347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of novel mutations including a double mutation in patients with inherited cardiomyopathy by a targeted sequencing approach using the Ion Torrent PGM system.
    Zhao Y; Cao H; Song Y; Feng Y; Ding X; Pang M; Zhang Y; Zhang H; Ding J; Xia X
    Int J Mol Med; 2016 Jun; 37(6):1511-20. PubMed ID: 27082122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term outcome of 4 Korean families with hypertrophic cardiomyopathy caused by 4 different mutations.
    Choi JO; Yu CW; Chun Nah J; Rang Park J; Lee BS; Jeong Choi Y; Cho BR; Lee SC; Woo Park S; Kimura A; Euy Park J
    Clin Cardiol; 2010 Jul; 33(7):430-8. PubMed ID: 20641121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic predictive value of gene mutations in Japanese patients with hypertrophic cardiomyopathy.
    Chida A; Inai K; Sato H; Shimada E; Nishizawa T; Shimada M; Furutani M; Furutani Y; Kawamura Y; Sugimoto M; Ishihara J; Fujiwara M; Soga T; Kawana M; Fuji S; Tateno S; Kuraishi K; Kogaki S; Nishimura M; Ayusawa M; Ichida F; Yamazawa H; Matsuoka R; Nonoyama S; Nakanishi T
    Heart Vessels; 2017 Jun; 32(6):700-707. PubMed ID: 27885498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The genotype-phenotype correlation of MYH7 gene G15391A mutation and MYBPC3 gene G12101A mutation in familial hypertrophic cardiomyopathy].
    WANG H; ZOU YB; WANG JZ; SONG L; SUN K; SONG XD; WANG XJ; ZHANG CN; HUI RT
    Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Dec; 36(12):1059-62. PubMed ID: 19134269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disease penetrance and risk stratification for sudden cardiac death in asymptomatic hypertrophic cardiomyopathy mutation carriers.
    Michels M; Soliman OI; Phefferkorn J; Hoedemaekers YM; Kofflard MJ; Dooijes D; Majoor-Krakauer D; Ten Cate FJ
    Eur Heart J; 2009 Nov; 30(21):2593-8. PubMed ID: 19666645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic analysis of monoallelic double MYH7 mutations responsible for familial hypertrophic cardiomyopathy.
    Wang B; Wang J; Wang LF; Yang F; Xu L; Li WX; He Y; Zuo L; Yang QL; Shao H; Hu D; Liu LW
    Mol Med Rep; 2019 Dec; 20(6):5229-5238. PubMed ID: 31638223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sudden cardiac death in hypertrophic cardiomyopathy. Variability in phenotypic expression of beta-myosin heavy chain mutations.
    Marian AJ; Mares A; Kelly DP; Yu QT; Abchee AB; Hill R; Roberts R
    Eur Heart J; 1995 Mar; 16(3):368-76. PubMed ID: 7789380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel deletions in MYH7 and MYBPC3 identified in Indian families with familial hypertrophic cardiomyopathy.
    Waldmüller S; Sakthivel S; Saadi AV; Selignow C; Rakesh PG; Golubenko M; Joseph PK; Padmakumar R; Richard P; Schwartz K; Tharakan JM; Rajamanickam C; Vosberg HP
    J Mol Cell Cardiol; 2003 Jun; 35(6):623-36. PubMed ID: 12788380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coexistence of Digenic Mutations in Both Thin (TPM1) and Thick (MYH7) Filaments of Sarcomeric Genes Leads to Severe Hypertrophic Cardiomyopathy in a South Indian FHCM.
    Selvi Rani D; Nallari P; Dhandapany PS; Rani J; Meraj K; Ganesan M; Narasimhan C; Thangaraj K
    DNA Cell Biol; 2015 May; 34(5):350-9. PubMed ID: 25607779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic determinants of clinical phenotype in hypertrophic cardiomyopathy.
    Velicki L; Jakovljevic DG; Preveden A; Golubovic M; Bjelobrk M; Ilic A; Stojsic S; Barlocco F; Tafelmeier M; Okwose N; Tesic M; Brennan P; Popovic D; Ristic A; MacGowan GA; Filipovic N; Maier LS; Olivotto I
    BMC Cardiovasc Disord; 2020 Dec; 20(1):516. PubMed ID: 33297970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic diagnosis of hypertrophic cardiomyopathy using mass spectrometry DNA arrays and high resolution melting.
    Santos S; Lança V; Oliveira H; Branco P; Silveira L; Marques V; Brito D; Madeira H; Bicho M; Fernandes AR
    Rev Port Cardiol; 2011 Jan; 30(1):7-18. PubMed ID: 21425739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical features, spectrum of causal genetic mutations and outcome of hypertrophic cardiomyopathy in South Africans.
    Ntusi NA; Shaboodien G; Badri M; Gumedze F; Mayosi BM
    Cardiovasc J Afr; 2016; 27(3):152-158. PubMed ID: 27841901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel mutation of the beta myosin heavy chain gene responsible for familial hypertrophic cardiomyopathy.
    Wang J; Xu SJ; Zhou H; Wang LJ; Hu B; Fang F; Zhang XM; Luo YW; He XY; Zhuang SW; Li XM; Liu ZM; Hu DY
    Clin Cardiol; 2009 Sep; 32(9):E16-21. PubMed ID: 19645038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.